Phase I: Will this treatment immediately kill people?
Phase II: Does this methodology seem like the right methodology to show some sort of result in larger trials?
Phase III: Does the treatment work better than some type of placebo for at least a few weeks without causing obvious and unjustifiable harms during those few weeks.
Phase IV: Let's shift our marketing budget into R&D so that we can claim to be unprofitable to congress.
Yeah but they (usually) don't have to be tested against the existing standard of care, or tested longer than a few weeks. So really it's misleading to claim that Phase III trials guarantee anything other than the extremely minimal standard of safety and efficacy that they actually guarantee.
"A research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes."
A phase 1 clinical trial is used to determine safety (including dosage) and involves far fewer people than a stage III clinical trial.
For Biotech startups, the companies value usually increases with each successfully completed trial. Conversely, the cost of conducting a trail also increases at each stage.
Phase 0: exploration of effectiveness
Phase I: is the treatment safe?
Phase II: does the treatment work?
Phase III: is the treatment better than existing alternatives?
Phase IV: After approval, monitor the long term effects of the treatment.